CardiaMetrics is proud to announce that we have been selected to join the Deeptech Accelerator program led by Bpifrance, becoming the only startup from Normandy to be part of this prestigious cohort.
This recognition marks an important milestone in our journey to transform heart failure care through innovative remote monitoring technologies.
Read the full media coverage by Ouest-France
Recognition of Our Deeptech Vision
The Deeptech Accelerator supports high-impact startups developing breakthrough technologies grounded in strong scientific foundations. CardiaMetrics’ selection reflects the relevance of our approach combining advanced sensing technologies, machine learning, and clinical research to improve the management of heart failure patients.
Being part of this program will help us structure our growth, strengthen our industrial strategy, and accelerate clinical development, while benefiting from mentorship, funding support, and access to a powerful innovation ecosystem.
Strengthening Our Development Roadmap
Since our creation, CardiaMetrics has focused on building a clinically driven innovation, working closely with healthcare professionals and research partners to validate the safety and performance of our technology.
Participation in the Deeptech Accelerator will enable us to:
- Accelerate product development and regulatory readiness
- Expand clinical evidence generation
- Reinforce our strategic positioning in the heart failure monitoring market
- Scale our impact across France and internationally
A Collective Achievement
This milestone reflects the dedication of our growing team, the trust of our investors, and the support of our clinical partners.
We are honored to contribute to the dynamism of the Normandy deeptech ecosystem and to help position French innovation at the forefront of cardiovascular care.
Stay tuned for more updates as we continue to advance toward the next stages of clinical validation and market access.